Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat

Lizomar J M P Moia, Hideki Matsui, Guilherme A M de Barros, Kazuhito Tomizawa, Kazuhiro Miyamoto, Yoshihiro Kuwata, Masaaki Tokuda, Toshifumi Itano, Osamu Hatase

Research output: Contribution to journal › Article

49 Citations (Scopus)

Abstract

Calcineurin (CaN) immunoreactivity and content increased markedly in kindled rat brain, and this increment was due to CaN in the membrane fraction. Investigation of the effects of cyclosporin A and FK506 (immunosuppressants which inhibit CaN activity in T lymphcytes) in the kindling phenomena showed that the kindling stage progression was reversibly blocked by these drugs. These findings suggest that calcineurin may play an essential role in acquiring epileptogenesis in kindling.

Original languageEnglish
Pages (from-to)337-341
Number of pages5
JournalBrain Research
Volume648
Issue number2
DOIs
Publication statusPublished - Jun 20 1994
Externally publishedYes

Fingerprint

Calcineurin
Tacrolimus
Cyclosporine
Immunosuppressive Agents
Membranes
Calcineurin Inhibitors
Brain
Pharmaceutical Preparations

Keywords

  • Calcineurin
  • Cyclosporin A
  • FK506
  • Hippocampus
  • Immunosuppressant
  • Kindling
  • Neocortex
  • Rat brain

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Moia, L. J. M. P., Matsui, H., de Barros, G. A. M., Tomizawa, K., Miyamoto, K., Kuwata, Y., ... Hatase, O. (1994). Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. Brain Research, 648(2), 337-341. https://doi.org/10.1016/0006-8993(94)91138-X

Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. / Moia, Lizomar J M P; Matsui, Hideki; de Barros, Guilherme A M; Tomizawa, Kazuhito; Miyamoto, Kazuhiro; Kuwata, Yoshihiro; Tokuda, Masaaki; Itano, Toshifumi; Hatase, Osamu.

In: Brain Research, Vol. 648, No. 2, 20.06.1994, p. 337-341.

Research output: Contribution to journal › Article

Moia, LJMP, Matsui, H, de Barros, GAM, Tomizawa, K, Miyamoto, K, Kuwata, Y, Tokuda, M, Itano, T & Hatase, O 1994, 'Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat', Brain Research, vol. 648, no. 2, pp. 337-341. https://doi.org/10.1016/0006-8993(94)91138-X
Moia LJMP, Matsui H, de Barros GAM, Tomizawa K, Miyamoto K, Kuwata Y et al. Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. Brain Research. 1994 Jun 20;648(2):337-341. https://doi.org/10.1016/0006-8993(94)91138-X
Moia, Lizomar J M P ; Matsui, Hideki ; de Barros, Guilherme A M ; Tomizawa, Kazuhito ; Miyamoto, Kazuhiro ; Kuwata, Yoshihiro ; Tokuda, Masaaki ; Itano, Toshifumi ; Hatase, Osamu. / Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. In: Brain Research. 1994 ; Vol. 648, No. 2. pp. 337-341.
@article{4f2ba231f5bc4e09840bb013cf566fd9,
title = "Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat",
abstract = "Calcineurin (CaN) immunoreactivity and content increased markedly in kindled rat brain, and this increment was due to CaN in the membrane fraction. Investigation of the effects of cyclosporin A and FK506 (immunosuppressants which inhibit CaN activity in T lymphcytes) in the kindling phenomena showed that the kindling stage progression was reversibly blocked by these drugs. These findings suggest that calcineurin may play an essential role in acquiring epileptogenesis in kindling.",
keywords = "Calcineurin, Cyclosporin A, FK506, Hippocampus, Immunosuppressant, Kindling, Neocortex, Rat brain",
author = "Moia, {Lizomar J M P} and Hideki Matsui and {de Barros}, {Guilherme A M} and Kazuhito Tomizawa and Kazuhiro Miyamoto and Yoshihiro Kuwata and Masaaki Tokuda and Toshifumi Itano and Osamu Hatase",
year = "1994",
month = "6",
day = "20",
doi = "10.1016/0006-8993(94)91138-X",
language = "English",
volume = "648",
pages = "337--341",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat

AU - Moia, Lizomar J M P

AU - Matsui, Hideki

AU - de Barros, Guilherme A M

AU - Tomizawa, Kazuhito

AU - Miyamoto, Kazuhiro

AU - Kuwata, Yoshihiro

AU - Tokuda, Masaaki

AU - Itano, Toshifumi

AU - Hatase, Osamu

PY - 1994/6/20

Y1 - 1994/6/20

N2 - Calcineurin (CaN) immunoreactivity and content increased markedly in kindled rat brain, and this increment was due to CaN in the membrane fraction. Investigation of the effects of cyclosporin A and FK506 (immunosuppressants which inhibit CaN activity in T lymphcytes) in the kindling phenomena showed that the kindling stage progression was reversibly blocked by these drugs. These findings suggest that calcineurin may play an essential role in acquiring epileptogenesis in kindling.

AB - Calcineurin (CaN) immunoreactivity and content increased markedly in kindled rat brain, and this increment was due to CaN in the membrane fraction. Investigation of the effects of cyclosporin A and FK506 (immunosuppressants which inhibit CaN activity in T lymphcytes) in the kindling phenomena showed that the kindling stage progression was reversibly blocked by these drugs. These findings suggest that calcineurin may play an essential role in acquiring epileptogenesis in kindling.

KW - Calcineurin

KW - Cyclosporin A

KW - FK506

KW - Hippocampus

KW - Immunosuppressant

KW - Kindling

KW - Neocortex

KW - Rat brain

UR - http://www.scopus.com/inward/record.url?scp=0028200736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028200736&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)91138-X

DO - 10.1016/0006-8993(94)91138-X

M3 - Article

C2 - 7522929

AN - SCOPUS:0028200736

VL - 648

SP - 337

EP - 341

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -

Access to Document